已收盤 02-06 16:00:00 美东时间
-0.160
-0.48%
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38
Ratings for Trupanion (NASDAQ:TRUP) were provided by 4 analysts in the past thr...
01-30 02:01
Stifel analyst Jonathan Block maintains Trupanion (NASDAQ:TRUP) with a Hold and lowers the price target from $42 to $38.
01-29 23:54
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
Cantor Fitzgerald analyst Ryan Tunis maintains Trupanion (NASDAQ:TRUP) with a Neutral and lowers the price target from $50 to $42.
01-14 21:52
今日重点评级关注:HC Wainwright & Co.:维持Pyxis Oncology"买入"评级,目标价从5美元升至7美元;Stifel:维持Oculis Holding"买入"评级,目标价从35美元升至40美元
2025-12-22 15:05
Piper Sandler analyst John Barnidge maintains Trupanion (NASDAQ:TRUP) with a Overweight and lowers the price target from $67 to $60.
2025-12-19 20:53
今日重点评级关注:Oppenheimer:维持Olema Pharmaceuticals"跑赢大市"评级,目标价从22美元升至45美元;Bernstein:维持Atlassian"跑赢大市"评级,目标价从290美元升至304美元
2025-11-19 11:01
Stifel analyst Jonathan Block maintains Trupanion (NASDAQ:TRUP) with a Hold and lowers the price target from $45 to $42.
2025-11-18 21:03
Trupanion (NASDAQ:TRUP) sees Q4 sales of $371.000 million-$377.000 million vs $369.756 million analyst estimate.
2025-11-07 07:02